Cargando…

Pioglitazone use and risk of bladder cancer: population based cohort study

Objective To determine whether pioglitazone compared with other antidiabetic drugs is associated with an increased risk of bladder cancer in people with type 2 diabetes. Design Population based cohort study. Setting General practices contributing data to the United Kingdom Clinical Practice Research...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuccori, Marco, Filion, Kristian B, Yin, Hui, Yu, Oriana H, Platt, Robert W, Azoulay, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816602/ https://www.ncbi.nlm.nih.gov/pubmed/27029385 http://dx.doi.org/10.1136/bmj.i1541

Ejemplares similares

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
por: Azoulay, Laurent, et al.
Publicado: (2012)

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
por: Douros, Antonios, et al.
Publicado: (2018)

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
por: Hicks, Blánaid M, et al.
Publicado: (2018)

Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2023)

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
por: Abrahami, Devin, et al.
Publicado: (2018)

Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population‐based assessment
por: Yu, Ya‐Hui, et al.
Publicado: (2021)

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study
por: Gupta, Sunil, et al.
Publicado: (2015)

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
por: Neumann, A., et al.
Publicado: (2012)

Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
por: Tseng, Chin-Hsiao
Publicado: (2012)

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
por: Azoulay, Laurent, et al.
Publicado: (2016)

Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review
por: Gómez-Izquierdo, Juan, et al.
Publicado: (2020)

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
por: Yang, Shao-ling, et al.
Publicado: (2018)

Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
por: Filipova, Elena, et al.
Publicado: (2017)

Pioglitazone, bladder cancer, and detection bias
por: Dolin, Paul
Publicado: (2014)

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study
por: Abrahami, Devin, et al.
Publicado: (2018)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
por: Song, Sun Ok, et al.
Publicado: (2012)

Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2022)

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
por: Tang, Huilin, et al.
Publicado: (2018)

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
por: Lewis, James D., et al.
Publicado: (2011)

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
por: Balaji, V., et al.
Publicado: (2014)

Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study
por: Renoux, Christel, et al.
Publicado: (2015)

Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
por: Qu, Hua, et al.
Publicado: (2017)

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
por: Juurlink, David N, et al.
Publicado: (2009)

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
por: Yan, Huaqing, et al.
Publicado: (2018)

Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes
por: Abdel-Hamid, Ahmed A. M., et al.
Publicado: (2021)

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes
por: Yu, Ya-Hui, et al.
Publicado: (2022)

The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study
por: Deng, Lan, et al.
Publicado: (2021)

Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
por: Platt, Robert W., et al.
Publicado: (2016)

Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
por: DONG, YOUHONG, et al.
Publicado: (2016)

A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone
por: Agrawal, Prabhat, et al.
Publicado: (2021)

The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
por: Li, Yan-Rong, et al.
Publicado: (2021)

Pioglitazone use and Parkinson’s disease: a retrospective cohort study in Taiwan
por: Wu, Hsiu-Feng, et al.
Publicado: (2018)

Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
por: Korhonen, Pasi, et al.
Publicado: (2016)

Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects
por: Shahid, Muhammad, et al.
Publicado: (2020)

Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
por: Ferrara, Assiamira, et al.
Publicado: (2011)

Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
por: Jin, Sang-Man, et al.
Publicado: (2014)

Type 2 diabetes mellitus and risk of community-acquired pneumonia: a systematic review and meta-analysis of observational studies
por: Brunetti, Vanessa C., et al.
Publicado: (2021)

Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population‐Based Cohort Study
por: Rouette, Julie, et al.
Publicado: (2022)

Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016)

Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
por: Lefebvre, Claire, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mm86jpqpp5hreqdnn7cnlp7gte